Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication for the unaudited (standalone and consolidated) financial results of the Company for the quarter and nine months ended 31 December 2025
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has shared copies of the newspaper advertisement publishing its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. This is a routine regulatory disclosure required under SEBI listing rules, where listed companies must publish their quarterly results in newspapers for public awareness. The detailed numbers (revenue, profit, margins) are expected to be available in the actual results document already filed with the exchanges. Investors should refer to the earlier results filing for the specific financial performance figures.
This is a standard compliance disclosure with no direct impact on shareholders or stock price. Investors should look at the already-filed Q3 FY26 results for actual performance metrics and business outlook.